
Ophirex Appoints Jeremy Gowler as Chief Executive Officer
Gowler Brings More than 20 Years of Biopharmaceutical Industry Leadership to Ophirex, Strengthening its Late-Stage Development and Growth Strategy CORTE MADERA, Calif. – Ophirex, Inc., a registered Public Benefit Corporation developing an oral field treatment to address the global unmet medical needs of snakebite victims, today announced the appointment of Jeremy Gowler as chief executive officer. Mr. Gowler also joins the Ophirex Board of Directors. … Continue reading Ophirex Appoints Jeremy Gowler as Chief Executive Officer